Unknown

Dataset Information

0

Transcription profiling by array of human breast cancer tumors following anastrozole treatment for 2 and 16 weeks


ABSTRACT: Analysis of breast cancer tumors following anastrozole treatment for 2 weeks and 16 weeks. The aromatase inhibitor anastrozole is an anti-estrogen drug used to treat postmenopausal women with breast cancer. Data provide insight into the molecular mechanism of action of anastrozole on hypoxia and proliferation metagenes. Core-cut tumor biopsies were collected from 81 postmenopausal women with stage I to IIIB ER+ early breast cancer before and after 2 weeks of anastrozole treatment. Further tumor biopsies were obtained from 20 of these patients after 16 weeks of anastrozole treatment prior to surgery

ORGANISM(S): Homo sapiens

SUBMITTER: Ghazoui Z 

PROVIDER: S-ECPF-MTAB-520 | biostudies-other | 2011 May

REPOSITORIES: biostudies-other

Similar Datasets

| S-ECPF-GEOD-7515 | biostudies-other
| S-ECPF-MTAB-887 | biostudies-other
| S-ECPF-GEOD-8920 | biostudies-other
| S-ECPF-GEOD-16515 | biostudies-other
| S-ECPF-MTAB-1196 | biostudies-other
| S-ECPF-MTAB-965 | biostudies-other
| S-ECPF-GEOD-6532 | biostudies-other
| S-ECPF-GEOD-39870 | biostudies-other
| S-ECPF-MEXP-440 | biostudies-other
| S-ECPF-TABM-1220 | biostudies-other